NervGen Pharma Corp. (NGEN) — Financial Flexibility Index
NervGen Pharma Corp. (NGEN) has a Financial Flexibility Index of -0.55x as of March 2026. Free cash flow of $-8.34 Million (operating CF $-8.34 Million minus capex $4.18) represents -1% of total liabilities ($15.21 Million). Check NGEN PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
NervGen Pharma Corp. Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for NervGen Pharma Corp. across 8 annual periods. See NGEN working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for NervGen Pharma Corp. (2018–2025)
Year-by-year free cash flow to debt coverage for NervGen Pharma Corp.. For the full company profile including market capitalisation, see NGEN market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.99x | $-19.50 Million | $-19.50 Million | $19.73 Million | ▲ +0.8% |
| 2024 | -1.00x | $-16.83 Million | $-16.83 Million | $16.90 Million | ▼ -34.5% |
| 2023 | -0.74x | $-11.29 Million | $-11.30 Million | $15.25 Million | ▲ +56.6% |
| 2022 | -1.71x | $-17.61 Million | $-17.63 Million | $10.32 Million | ▲ +77.8% |
| 2021 | -7.67x | $-8.33 Million | $-8.33 Million | $1.09 Million | ▲ +8.2% |
| 2020 | -8.35x | $-6.32 Million | $-6.32 Million | $756.78K | ▲ +4.7% |
| 2019 | -8.76x | $-8.31 Million | $-8.31 Million | $949.14K | ▼ -391.1% |
| 2018 | -1.78x | $-1.04 Million | $-1.04 Million | $581.26K | — |